What's Happening

Indicated for the acute treatment of migraine with or without aura

For the treatment of anxiety disorders in adults receiving stable, evenly divided, three times daily dosing with lorazepam tablets

A once-daily medication indicated to help lower blood sugar with type 2 diabetes, in conjunction with diet and exercise

Indicated for the acute treatment of migraine with or without aura

Indicated for the preventive treatment of episodic migraine

Adjunct treatment to diet and exercise to improve glycemic control in adults with type 2 diabetes

Adjunct treatment to diet and exercise to improve glycemic control in adults with type 2 diabetes

This is the first time a generic has been approved for Xeljanz XR – other formulations of Xeljanz have received generic approvals, but this new generic approval applies to the extended-release formulation. For the treatment of moderate-to-severe active rheumatoid arthritis, active psoriatic arthritis, or ulcerative colitis

This is the first time a generic has been approved for Duexis. For the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, and to decrease the risk of developing upper gastrointestinal ulcers

This is the first time a generic has been approved for Belbuca. For the management of pain severe enough to require daily, around the clock, long-term opioid treatment for which alternative treatment options are inadequate